Synjardy

Congestive Heart Failure, Physical Activity, Monotherapy + 8 more
Treatment
5 FDA approvals
20 Active Studies for Synjardy

What is Synjardy

EmpagliflozinThe Generic name of this drug
Treatment SummaryMetformin is a medication used to treat type 2 diabetes. It is the first-line drug of choice for managing type 2 diabetes and is taken by more than 120 million people around the world. Metformin lowers blood sugar levels without causing hypoglycemia, increases insulin sensitivity, and leads to modest weight loss. It was first approved in Canada in 1972 and in the United States in 1995. Metformin is available in regular and extended-release form.
Jardianceis the brand name
image of different drug pills on a surface
Synjardy Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Jardiance
Empagliflozin
2014
24

Approved as Treatment by the FDA

Empagliflozin, also called Jardiance, is approved by the FDA for 5 uses including Type 2 Diabetes and Cardiovascular Mortality .
Type 2 Diabetes
Used to treat Type 2 Diabetes Mellitus in combination with Metformin
Cardiovascular Mortality
Physical Activity
Used to treat Exercise in combination with Metformin
Diet
Used to treat Diet in combination with Metformin
Cardiovascular Diseases

Effectiveness

How Synjardy Affects PatientsInsulin is a hormone that helps control the amount of sugar in the blood. People with Type II diabetes have a decreased sensitivity to insulin, which means their pancreas cannot keep up with regulating their sugar levels. Metformin works to reduce the amount of sugar produced by the liver and absorbed by the intestines, as well as increase the body's sensitivity to insulin. In a clinical trial, people taking Metformin had decreased fasting blood sugar levels by an average of 59 mg/dL, while those taking a placebo had increased levels by 6.3 mg/dL. Metformin also decreased HbA1c by 1
How Synjardy works in the bodyMetformin works in several ways to reduce blood glucose levels. It decreases the amount of glucose produced in the liver, decreases the amount of glucose absorbed from food in the intestines, and makes cells more sensitive to insulin. Metformin enters liver cells through a transporter called OCT1, and accumulates in the mitochondria. It blocks the production of energy in the mitochondria, turning on an enzyme called AMPK. This helps to decrease fat production and increase fat burning, as well as reduce glucose production in the liver. In the intestines, metformin increases anaerobic glucose metabolism, leading to less net glucose uptake and

When to interrupt dosage

The suggested dose of Synjardy is contingent upon the recognized disorder, including Diet, inadequate response to metformin and Diabetic Ketoacidosis. The quantity differs, in line with the methodology of delivery (e.g. Oral or Tablet - Oral) listed in the table below.
Condition
Dosage
Administration
Type 2 Diabetes
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Symptomatic Congestive Heart Failure
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Congestive Heart Failure
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Hospitalizations
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Cardiovascular Mortality
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Monotherapy
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Cardiovascular Diseases
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Physical Activity
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Ejection fraction decreased
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Therapeutic procedure
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral
Diet
10.0 mg, 25.0 mg, , 5.0 mg, 12.5 mg
, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, extended release, Tablet, extended release - Oral

Warnings

Synjardy Contraindications
Condition
Risk Level
Notes
Kidney Failure
Do Not Combine
Renal Dialysis
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Empagliflozin may interact with Pulse Frequency
There are 20 known major drug interactions with Synjardy.
Common Synjardy Drug Interactions
Drug Name
Risk Level
Description
Acetazolamide
Minor
Empagliflozin may increase the diuretic activities of Acetazolamide.
Ambrisentan
Minor
Empagliflozin may increase the hypotensive activities of Ambrisentan.
Amiloride
Minor
Empagliflozin may increase the diuretic activities of Amiloride.
Angiotensin 1-7
Minor
Empagliflozin may increase the hypotensive activities of Angiotensin 1-7.
Azosemide
Minor
Empagliflozin may increase the diuretic activities of Azosemide.
Synjardy Toxicity & Overdose RiskThe toxic dose of metformin in rats is 1000mg/kg when taken orally, 500mg/kg when given through the abdomen, and 300mg/kg when injected under the skin. The toxic dose in mice is 1450mg/kg orally, 420mg/kg through the abdomen, and 225mg/kg when injected under the skin. Taking too much metformin can lead to lactic acidosis, a serious condition where too much acid builds up in the blood. Risk factors for lactic acidosis include kidney problems, being over 65 years old, taking certain medications, drinking too much alcohol, or having liver disease
image of a doctor in a lab doing drug, clinical research

Synjardy Novel Uses: Which Conditions Have a Clinical Trial Featuring Synjardy?

346 active trials are assessing the potential of Synjardy in treating Type 2 Diabetes, Type 1 Diabetes and inadequate response to Metformin therapy.
Condition
Clinical Trials
Trial Phases
Type 2 Diabetes
192 Actively Recruiting
Phase 2, Not Applicable, Early Phase 1, Phase 1, Phase 4, Phase 3
Monotherapy
1 Actively Recruiting
Phase 1, Phase 2
Symptomatic Congestive Heart Failure
0 Actively Recruiting
Cardiovascular Mortality
0 Actively Recruiting
Cardiovascular Diseases
0 Actively Recruiting
Ejection fraction decreased
0 Actively Recruiting
Therapeutic procedure
0 Actively Recruiting
Congestive Heart Failure
315 Actively Recruiting
Phase 2, Phase 3, Not Applicable, Phase 1, Early Phase 1, Phase 4
Hospitalizations
2 Actively Recruiting
Not Applicable
Physical Activity
39 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Early Phase 1
Diet
5 Actively Recruiting
Not Applicable

Synjardy Reviews: What are patients saying about Synjardy?

5Patient Review
10/17/2018
Synjardy for Type 2 Diabetes Mellitus
Synjardy has been great for me. I brought my A1C down from 10.6 to 6.0 in a year, and experienced zero negative side effects.
4Patient Review
4/17/2016
Synjardy for Type 2 Diabetes Mellitus
4Patient Review
11/9/2017
Synjardy for Type 2 Diabetes Mellitus
2.3Patient Review
1/30/2019
Synjardy for Type 2 Diabetes Mellitus
My A1C rose from 6.5 to 8.7 after my doctor switched me from Farxiga to Synjardy. I found the latter drug much less effective than the former.
2Patient Review
9/4/2018
Synjardy for Type 2 Diabetes Mellitus
I unfortunately got a yeast infection from this medication.
1.7Patient Review
5/12/2019
Synjardy for Type 2 Diabetes Mellitus
Thirst, yeast infection, and constant trips to the bathroom are all unfortunately common side effects of this medication. I've been taking it for five months now and have had to deal with a lot of discomfort as a result.
1Patient Review
9/9/2018
Synjardy for Type 2 Diabetes Mellitus
I was worried from the start with this prescription. My blood sugar shot up, and even when I increased the dose as directed, it didn't seem to be effective.
1Patient Review
9/8/2021
Synjardy for Type 2 Diabetes Mellitus
I was in a lot of pain after injuring my knee and was prescribed Synjardy. However, this medication caused me more pain and fatigue than the original injury. I stopped taking it and felt better the next day.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about synjardy

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Synjardy used for?

"This medication is a combination of 2 drugs: empagliflozin and metformin. It is used with a proper diet and exercise program to lower blood sugar in people with type 2 diabetes. Controlling blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems."

Answered by AI

What is the side effects of Synjardy?

"Some possible causes of these symptoms include low blood sugar, a urinary tract infection, a stuffy or runny nose and sore throat, yeast infections in females, diarrhea, nausea or vomiting, gas, stomach discomfort, indigestion, weakness, or a headache."

Answered by AI

What is the difference between Synjardy and metformin?

"Synjardy contains both metformin and the drug empagliflozin. Metformin lowers blood sugar levels through several mechanisms, and the addition of empagliflozin provides additional blood sugar lowering effects."

Answered by AI

Are Jardiance and Synjardy the same thing?

"Jardiance is a medication used to treat type 2 diabetes. It is available as a standalone tablet or as a combination tablet with metformin. The medication works by helping the body to better use insulin. Side effects may include nausea, diarrhea, and headaches. Jardiance is a brand-name medication and costs can vary depending on insurance coverage."

Answered by AI

Clinical Trials for Synjardy

Have you considered Synjardy clinical trials? We made a collection of clinical trials featuring Synjardy, we think they might fit your search criteria.
Have you considered Synjardy clinical trials? We made a collection of clinical trials featuring Synjardy, we think they might fit your search criteria.
Have you considered Synjardy clinical trials? We made a collection of clinical trials featuring Synjardy, we think they might fit your search criteria.